Clinical Trial

Accelerated ART Initiation for PWHIV Who Are Out of Care

Study acronym: ACCELERATE
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 5, 2026 (before its estimated August 9, 2026 completion). Its status may not reflect the trial's current state.
Summary
The main purpose of the study is to evaluate the effectiveness, of the ACCELERATE model of care to achieve HIV viral suppression at Week 24. The study will also assess the acceptability, appropriateness, feasibility, and sustainability of the ACCELERATE model of care. The ACCELERATE model combines a standardized method for outreach, the use of telehealth for rapid access to an HIV care provider, a simplified pre-approved HIV regimen, a free 30-day medication starter supply, and re-linkage to medical care.
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-06
notable Primary completion pushed: 2026-05-01 -> 2026-08-09 2026-08-06
minor Completion pushed: 2026-11-01 -> 2027-08-09 2026-08-06
Trial Details
NCT Number NCT06374758
Lead Sponsor University of Missouri-Columbia
Collaborators: Gilead Sciences
Conditions HIV Infections, ART, Noncompliance, Patient
Enrollment 120 participants
Start Date 2024-04-29
Primary Completion 2026-08-09 (estimated)
Study Completion 2027-08-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-05